5 Best Dow Dividend Stocks To Watch For 2015

5 Best Dow Dividend Stocks To Watch For 2015: Covidien PLC (COV)

Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its businesses through three segments: Medical Devices, which includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products; Pharmaceuticals, which includes the development, manufacture and distribution of specialty pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, SharpSafety products and original equipment manufacturer products. In May 2012, it acquired Newport Medical Instruments, Inc. In May 2012, it acquired superDimension, Ltd. In June 2012, the Company acquired Oridion Systems Ltd. In October 2012, its Mallinckrodt acquired CNS Therapeutics, Inc. In January 2013, the Company acquired CV Ingenuity. Advisors' Opinion:

• [By Keith Speights]

  Product recalls usually hurt companies. Covidien's (NYSE: COV  ) shares were temporarily affected by the company's recall of surgical tools last year. Johnson & Johnson stock took a hit in 2010 and early 2011 partially due to recalls of several products.

• [By Laura Brodbeck]

  Friday

  Earnings Expected From: Covidien plc. (NYSE: COV), Eldorado Gold Corporation (NYSE: EGO), Vaalco Energy Inc. (NYSE: EGY) Economic Releases Expected: US Wholesale Trade, US non-farm payrolls

  Posted-In: Bank Of England European Central Bank Federal ReserveNews Eurozone Previews Global Economics Federal Reserve Markets Trading Ideas Best of Benzinga

• [By Ben Levisohn]

  Intuitive Surgical has gained 4.3% to $397.20 today, easily trumping the gains in other healthcare-equipment companies. Covidien(COV) has ticked down 0.3% to $60.08, Medt! ronic(MDT) has gained 0.5% to $52.97, Abbott Laboratories(ABT) has fallen 0.8% to $33.24, and C.R. Bard (BCR) is little changed at $114.52.

• [By Peter Stephens]

  As mentioned, sector peers such as Stryker (NYSE: SYK  ) and Covidien (NYSE: COV  ) are slightly ahead of St. Jude on EPS growth forecasts, with both companies forecast to increase EPS by 8% in 2014. Meanwhile, they are expected to increase EPS by 10% and 11%, respectively, in 2015. (Note that St. Jude and Stryker have calendar year-ends and Covidien has a September year-end.)

source from Top Penny Stocks For 2015:http://www.topstocksforum.com/5-best-dow-dividend-stocks-to-watch-for-2015.html